Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection

Ipilimumab, in combination with nivolumab, is one of the promising drugs that enhance the anti-tumor immune response of patients with advanced melanoma. Since the co-administration of nivolumab with ipilimumab in the neoadjuvant setting expands melanoma-reactive T cells at the primary site of melano...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Med (Lausanne)
Hauptverfasser: Fujimura, Taku, Kambayashi, Yumi, Sato, Yota, Tanita, Kayo, Amagai, Ryo, Hashimoto, Akira, Hidaka, Takanori, Aiba, Setsuya
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2019
Schlagworte:
Medicine
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607934/
https://ncbi.nlm.nih.gov/pubmed/31297373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00140
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge